Back to full study details
New York, NYNow Enrolling

Rectal Cancer Clinical Trial in New York, NY

Access cutting-edge rectal cancer treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Expert Care

Access rectal cancer specialists in New York at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related rectal cancer treatment provided free

About This Rectal Cancer Study in New York

The study researchers believe that a combination of the drugs trastuzumab and tucatinib, given with standard chemotherapy (capecitabine and oxaliplatin/FOLFOX), may help participants with rectal cancer.

Sponsor: Memorial Sloan Kettering Cancer Center

Apply for This New York Location

Check if you qualify for this rectal cancer clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Rectal Cancer Treatment Options in New York, NY

If you're searching for rectal cancer treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Why Consider a Clinical Trial for Rectal Cancer?

  • Access to new treatments before they're widely available
  • Receive care from leading rectal cancer specialists in New York
  • Contribute to medical research that could help future patients
  • Study-related care is typically provided at no cost
  • Close monitoring by a dedicated research team
  • Possible compensation for time and travel